![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Bentham Science Publishers
E-ISSN: 2212-3938|6|3|144-150
ISSN: 1574-8847
Source: Current Clinical Pharmacology, Vol.6, Iss.3, 2011-08, pp. : 144-150
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Adjuvant treatment for renal cell carcinoma
By Lam John S Belldegrun Arie S Figlin Robert A
Expert Opinion on Pharmacotherapy, Vol. 7, Iss. 6, 2006-04 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Targeted therapy in renal cell carcinoma
By Favaro Justin P George Daniel J
Expert Opinion on Investigational Drugs, Vol. 14, Iss. 10, 2005-10 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Dendritic Cell Therapy for Renal Cell Carcinoma
UroOncology, Vol. 3, Iss. 2, 2003-06 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Targeted-Therapy in Advanced Renal Cell Carcinoma
Current Medicinal Chemistry, Vol. 18, Iss. 11, 2011-04 ,pp. :